CUSIP 31189P102COMFATEQ4 2025
44 filings · latest Aug 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Redmile Group, LLC | 12.87M | $12.65M |
| 2 | Blackrock, Inc. | 10.18M | $10.00M |
| 3 | Vanguard Group Inc | 8.97M | $8.82M |
| 4 | Johnson & Johnson | 3.38M | $3.32M |
| 5 | Geode Capital Management, LLC | 2.47M | $2.43M |
| 6 | Renaissance Technologies LLC | 2.36M | $2.32M |
| 7 | State Street Corp | 2.27M | $2.23M |
| 8 | Two Sigma Investments, LP | 1.73M | $1.70M |
| 9 | Vestal Point Capital, LP |
| 4 | Jul 3, 2025 | Redmile Group, LLC | 13D/A | 14.9% | — | SEC |
| 5 | May 15, 2025 | Schonfeld Strategic Advisors LLC | 13G | 6.8% | 7.79M | SEC |
| 6 | May 9, 2025 | The Goldman Sachs Group, Inc. | 13G | 11.0% | 8.49M | SEC |
| 7 | Apr 23, 2025 | Blackrock, Inc. | 13G/A | 6.9% | 7.85M | SEC |
| 8 | Dec 26, 2024 | Redmile Group, LLC | 13D/A | 14.9% | — | SEC |
| 9 | Nov 14, 2024 | Point72 Asset Management, L.P. | 13G/A | — | — | SEC |
| 10 | Nov 8, 2024 | Blackrock, Inc. | 13G/A | 9.2% | 10.47M | SEC |
See the full Schedule 13D/13G history for Fate Therapeutics Inc.
Unlock full history| 1.73M |
| $1.69M |
| 10 | Two Sigma Advisers, LP | 1.65M | $1.62M |